BioCancell Ltd (BICL) - Financial and Strategic SWOT Analysis Review
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
BioCancell Ltd (BICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
BioCancell Ltd (BioCancell) is a biotechnology research and development company that focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancer-related diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The companys product pipeline candidates comprise BC-819 for the treatment of bladder cancer and BC-821, which being evaluated for the treatment of bladder cancer, ovarian cancer and pancreatic cancer. The company develops its products based on its proprietary, personalized cancer therapy approach H19, which plays a key role in the development, progress, drug resistance and metastasis of most human cancers. BioCancell is headquartered at Jerusalem, Israel.
BioCancell Ltd Key Recent Developments
Aug 14,2017: BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
BioCancell Ltd (BioCancell) is a biotechnology research and development company that focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancer-related diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The companys product pipeline candidates comprise BC-819 for the treatment of bladder cancer and BC-821, which being evaluated for the treatment of bladder cancer, ovarian cancer and pancreatic cancer. The company develops its products based on its proprietary, personalized cancer therapy approach H19, which plays a key role in the development, progress, drug resistance and metastasis of most human cancers. BioCancell is headquartered at Jerusalem, Israel.
BioCancell Ltd Key Recent Developments
Aug 14,2017: BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
TABLE OF CONTENTS
Section 1 - About the Company 5
BioCancell Ltd - Key Facts 5
BioCancell Ltd - Key Employees 6
BioCancell Ltd - Key Employee Biographies 7
BioCancell Ltd - Major Products and Services 8
BioCancell Ltd - History 9
BioCancell Ltd - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 Company Analysis 12
BioCancell Ltd - Business Description 12
BioCancell Ltd - Corporate Strategy 13
BioCancell Ltd - SWOT Analysis 14
SWOT Analysis - Overview 14
BioCancell Ltd - Strengths 14
BioCancell Ltd - Weaknesses 15
BioCancell Ltd - Opportunities 16
BioCancell Ltd - Threats 17
BioCancell Ltd - Key Competitors 18
Section 3 Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 Companys Lifesciences Financial Deals and Alliances 25
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
BioCancell Ltd, Recent Deals Summary 27
Section 5 Companys Recent Developments 28
Aug 14, 2017: BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors 28
Section 6 Appendix 29
Methodology 29
Ratio Definitions 29
About GlobalData 33
Contact Us 33
Disclaimer 33
List Of Tables
BioCancell Ltd, Key Facts 5
BioCancell Ltd, Key Employees 6
BioCancell Ltd, Key Employee Biographies 7
BioCancell Ltd, Major Products and Services 8
BioCancell Ltd, History 9
BioCancell Ltd, Other Locations 11
BioCancell Ltd, Key Competitors 18
BioCancell Ltd, Ratios based on current share price 19
BioCancell Ltd, Annual Ratios 20
BioCancell Ltd, Annual Ratios (Cont...1) 21
BioCancell Ltd, Interim Ratios 23
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
BioCancell Ltd, Recent Deals Summary 27
Currency Codes 29
Capital Market Ratios 29
Equity Ratios 30
Profitability Ratios 30
Cost Ratios 31
Liquidity Ratios 31
Leverage Ratios 32
Efficiency Ratios 32
List Of Figures
BioCancell Ltd, Performance Chart (2012 - 2016) 22
BioCancell Ltd, Ratio Charts 24
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
BioCancell Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 26
RELATED REPORTS
SAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
